Annual Total Long Term Liabilities
$460.00 K
-$117.00 K-20.28%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual total long term liabilities is $460.00 thousand, with the most recent change of -$117.00 thousand (-20.28%) on December 31, 2023.
- During the last 3 years, SLS annual total long term liabilities has fallen by -$5.29 million (-92.00%).
- SLS annual total long term liabilities is now -97.66% below its all-time high of $19.62 million, reached on December 31, 2013.
Performance
SLS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$161.00 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly total long term liabilities is $0.00, with the most recent change of -$161.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, SLS quarterly long term liabilities has dropped by -$460.00 thousand (-100.00%).
- SLS quarterly long term liabilities is now -100.00% below its all-time high of $21.02 million, reached on June 30, 2013.
Performance
SLS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SLS Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.3% | -100.0% |
3 y3 years | -92.0% | -100.0% |
5 y5 years | -91.9% | -100.0% |
SLS Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -51.4% | at low | -100.0% | at low |
5 y | 5-year | -92.0% | at low | -100.0% | at low |
alltime | all time | -97.7% | -100.0% | -100.0% | at low |
SELLAS Life Sciences Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $0.00(-100.0%) |
Jun 2024 | - | $161.00 K(-48.6%) |
Mar 2024 | - | $313.00 K(-32.0%) |
Dec 2023 | $460.00 K(-20.3%) | $460.00 K(+158.4%) |
Sep 2023 | - | $178.00 K(-41.1%) |
Jun 2023 | - | $302.00 K(-28.8%) |
Mar 2023 | - | $424.00 K(-26.5%) |
Dec 2022 | $577.00 K(-39.0%) | $577.00 K(-32.2%) |
Sep 2022 | - | $851.00 K(-12.0%) |
Jun 2022 | - | $967.00 K(-85.6%) |
Mar 2022 | - | $6.73 M(+611.4%) |
Dec 2021 | $946.00 K(-83.6%) | $946.00 K(-84.3%) |
Sep 2021 | - | $6.03 M(+0.9%) |
Jun 2021 | - | $5.97 M(+1.8%) |
Mar 2021 | - | $5.86 M(+1.9%) |
Dec 2020 | $5.75 M(+10.1%) | $5.75 M(-9.3%) |
Sep 2020 | - | $6.34 M(-1.0%) |
Jun 2020 | - | $6.41 M(+20.2%) |
Mar 2020 | - | $5.33 M(+2.0%) |
Dec 2019 | $5.23 M(-8.3%) | $5.23 M(-0.9%) |
Sep 2019 | - | $5.27 M(-0.4%) |
Jun 2019 | - | $5.30 M(-14.2%) |
Mar 2019 | - | $6.17 M(+8.4%) |
Dec 2018 | $5.70 M(-17.3%) | $5.70 M(-28.9%) |
Sep 2018 | - | $8.02 M(-16.5%) |
Jun 2018 | - | $9.60 M(+6.1%) |
Mar 2018 | - | $9.06 M(+31.5%) |
Dec 2017 | $6.89 M(+21.7%) | $6.89 M(-0.7%) |
Sep 2017 | - | $6.94 M(+0.7%) |
Jun 2017 | - | $6.89 M(+0.3%) |
Mar 2017 | - | $6.87 M(+21.4%) |
Dec 2016 | $5.66 M | $5.66 M(-11.3%) |
Sep 2016 | - | $6.38 M(+2.3%) |
Jun 2016 | - | $6.23 M(-46.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2016 | - | $11.73 M(+1.5%) |
Dec 2015 | $11.56 M(-28.6%) | $11.56 M(-12.2%) |
Sep 2015 | - | $13.16 M(-9.2%) |
Jun 2015 | - | $14.49 M(-6.9%) |
Mar 2015 | - | $15.56 M(-3.9%) |
Dec 2014 | $16.20 M(-17.4%) | $16.20 M(-5.0%) |
Sep 2014 | - | $17.05 M(-8.1%) |
Jun 2014 | - | $18.55 M(-2.1%) |
Mar 2014 | - | $18.95 M(-3.4%) |
Dec 2013 | $19.62 M(+73.4%) | $19.62 M(-2.5%) |
Sep 2013 | - | $20.12 M(-4.3%) |
Jun 2013 | - | $21.02 M(+78.7%) |
Mar 2013 | - | $11.76 M(+4.0%) |
Dec 2012 | $11.31 M(+17.2%) | $11.31 M(+3.1%) |
Sep 2012 | - | $10.97 M(+4.3%) |
Jun 2012 | - | $10.52 M(-7.6%) |
Mar 2012 | - | $11.39 M(+17.9%) |
Dec 2011 | $9.65 M(>+9900.0%) | $9.65 M(+132.1%) |
Sep 2011 | - | $4.16 M(-26.7%) |
Jun 2011 | - | $5.67 M(>+9900.0%) |
Mar 2011 | - | $33.00 K(+65.0%) |
Dec 2010 | $20.00 K(-44.4%) | $20.00 K(-53.5%) |
Sep 2010 | - | $43.00 K(+22.9%) |
Jun 2010 | - | $35.00 K(-32.7%) |
Mar 2010 | - | $52.00 K(+44.4%) |
Dec 2009 | $36.00 K(+800.0%) | $36.00 K(-55.0%) |
Sep 2009 | - | $80.00 K(+627.3%) |
Jun 2009 | - | $11.00 K(>+9900.0%) |
Mar 2009 | - | $0.00(-100.0%) |
Dec 2008 | $4000.00(>+9900.0%) | $4000.00(-55.6%) |
Sep 2008 | - | $9000.00(-30.8%) |
Jun 2008 | - | $13.00 K(>+9900.0%) |
Mar 2008 | - | $0.00(0.0%) |
Sep 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00 | $0.00 |
FAQ
- What is SELLAS Life Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual total long term liabilities year-on-year change?
- What is SELLAS Life Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly long term liabilities year-on-year change?
What is SELLAS Life Sciences annual total long term liabilities?
The current annual total long term liabilities of SLS is $460.00 K
What is the all time high annual total long term liabilities for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual total long term liabilities is $19.62 M
What is SELLAS Life Sciences annual total long term liabilities year-on-year change?
Over the past year, SLS annual total long term liabilities has changed by -$117.00 K (-20.28%)
What is SELLAS Life Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of SLS is $0.00
What is the all time high quarterly long term liabilities for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly total long term liabilities is $21.02 M
What is SELLAS Life Sciences quarterly long term liabilities year-on-year change?
Over the past year, SLS quarterly total long term liabilities has changed by -$460.00 K (-100.00%)